MBI at the largest scientific event on neuro-oncology in Latin America
Last Saturday (23), the founder of The Medulloblastoma Initiative (MBI), Fernando Goldsztein, participated in the Present-Future session of Snola 2024, the largest scientific neuro-oncology event in Latin America…
A big step for MBI
On Wednesday, March 6, the story of the Medulloblastoma Initiative (MBI) was presented to the Permanent Council of the OAS (Organization of American States), in Washington D.C., during the session dedicated to World Rare Disease Day…
United Voices at the International Symposium on Pediatric Neuro-Oncology
United voices at the International Symposium on Pediatric Neuro-Oncology: “in many places around the world, medulloblastoma is still diagnosed as it was almost 100 years ago”…
Brazil-American Chamber of Commerce Webinar
A Novel Approach: Brazil-US Partnerships in Health Science and Human Medicine — was the topic of the webinar held last Friday, October 27th…
Value Connections
Décadas de inovação, coragem e criatividade no mesmo palco: como alumni da PUCRS, Fernando Goldsztein (MBI), Dra. Maira Caleff (IMAMA) e Dr. Jorge Audy (Tecnopuc) abriram com chave de ouro o programa Conexões de Valor…
Final stretch for clinical studies
Dr. Duane Mitchell’s research includes pioneering clinical trials in medulloblastoma (Re-MATCH) and gliomas (PEACH), which confirmed the potential of this approach as a platform for cure. In the following interview, Dr. Mitchell…
Guri trophy
The founder of MBI was honored in August 2023 with the 24th Guri Trophy, an important award created by Grupo RBS, from the state of Rio Grande do Sul….
II Workshop do Consórcio Cure Group 4
II Cure Group 4 Consortium Workshop: Clinical trials are coming! The most important highlight of the Consortium’s second in-person workshop is the announcement…
Global stage
On June 2, 2023, MBI founder Fernando Goldsztein spoke at a summit of entrepreneurs hosted by MIT, the MBA program where Fernando studied…
First in-person workshop for researchers
“We hope to have paved the way for treatment of this disease,” says Roger Packer of Children’s National Hospital in Washington DC (USA)…
